4Filing Date: Sep 9, 2026

RxSight (RXST)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001193125-26-386841
Total Value$0
Trades2
Insiders1

Transaction Details

Wilterding Mark
Chief Financial Officer·Direct
Dispose · Dispose
Stock Option (right to buy)Derivative
Shares-258.77K
Price-
Total Value$0
Shares Owned After0
Transaction DateSep 5, 2026
Exercise Price$10.09
ExpiresJan 11, 2036
Footnotes ▸

On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $6.375 per share. | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of January 11, 2026 (the "Vesting Commencement Date"), and the remaining shares subject to the options shall vesting equally monthly on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) over the following three years, such that all of the shares subject to the option shall be fully vested four years from the Vesting Commencement Date.

Wilterding Mark
Chief Financial Officer·Direct
Grant · Acquire
Stock Option (right to buy)Derivative
Shares+258.77K
Price-
Total Value$0
Shares Owned After258.77K
Transaction DateSep 5, 2026
Exercise Price$6.38
ExpiresSep 4, 2033
Footnotes ▸

On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $6.375 per share. | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.

Post-Transaction Holdings

Wilterding Mark · Chief Financial Officer
SecuritySharesChange
Stock Option (right to buy)0-
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-05 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: RxSight, Inc. (RXST) CIK: 0001111485 --- Reporting Owner --- Name: Wilterding Mark CIK: 0002107187 Role: Officer (Chief Financial Officer) --- Derivative Transactions --- [Transaction #1] Security: Stock Option (right to buy) Date: 2026-09-05 | Code: D (Sale to issuer) Shares: -258,770 Exercise Price: $10.09 Exercisable: N/A | Expires: 2036-01-11 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F2] On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $6.375 per share. [F1] Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of January 11, 2026 (the "Vesting Commencement Date"), and the remaining shares subject to the options shall vesting equally monthly on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) over the following three years, such that all of the shares subject to the option shall be fully vested four years from the Vesting Commencement Date. [Transaction #2] Security: Stock Option (right to buy) Date: 2026-09-05 | Code: A (Grant or award) Shares: +258,770 Exercise Price: $6.38 Exercisable: N/A | Expires: 2033-09-04 Shares Owned After: 258,770 | Ownership: D (Direct) Footnotes: [F2] On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $6.375 per share. [F3] Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. --- Footnotes (Complete Index) --- F1: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of January 11, 2026 (the "Vesting Commencement Date"), and the remaining shares subject to the options shall vesting equally monthly on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) over the following three years, such that all of the shares subject to the option shall be fully vested four years from the Vesting Commencement Date. F2: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $6.375 per share. F3: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. --- Signature --- /s/ /s/ Jim Schindler, as Attorney-in-Fact (2026-09-09)

keid analysis is for reference only and does not constitute investment advice.